Exploration of medication patterns and new formulas for patented Chinese herbal medicine compound therapy for colorectal cancer in the past 20 years
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9
Abstract
Objective To analyze the medication usage and compatibility patterns of Chinese herbal medicine compound formulas in patents for intervening in colorectal cancer (CRC) over the past 20 years based on data mining, in order to provide a foundation for the development of new clinical medications. Methods Patented Chinese herbal medicine compound formulas for treating CRC were retrieved in the Wanfang database and China National Knowledge Infrastructure (CNKI) from their inception until January 17, 2024. Data analysis was performed using Excel 2019 software to assess drug frequency, properties, flavors, and meridian associations. SPSS Modeler 18.0 and SPSS Statistics 27 software suites were used for deriving drug association rules and performing cluster analysis. A complex network of core drug co-occurrences was constructed using Cytoscape 3.9.0 software to demonstrate associations of potential new formulations and new drugs. Results In total, 158 Chinese herbal medicine compound patents were included for CRC treatment, encompassing 448 Chinese herbal medicines. High-frequency medicines included Astragalus membranaceus (Huangqi), Hedyotis diffusa (Baihua Sheshecao), Poria cocos (Fuling), Atractylodes macrocephala (Baizhu), etc. The predominant type of medicine was deficiency-tonifying drugs, with the nature of the drugs being primarily cold and warm, and the flavors mostly bitter, sweet, and pungent. The meridians were chiefly associated with the liver, spleen, lung, and stomach. Herbs commonly used for pairs included Scutellariae barbatae Herba (Banzhilian), Astragalus membranaceus (Huangqi), Glycyrrhizae Radix et Rhizoma (Gancao), Atractylodes macrocephala (Baizhu), Poria cocos (Fuling), etc., while commonly used triangular medicines included Astragalus membranaceus (Huangqi) and Hedyotis diffusa (Baihua Sheshecao). There were four clusters of drugs, including Scutellaria barbata D. Don (Banzhilian)- Hedyotis diffusa (Baihua Sheshecao), and five groups of potential drugs, including “Phyllanthus emblica (Yuganzi)-Radix hedysari (Hongqi)-Semen punicae granati (Shiliuzi)-Zanthoxylum bungeanum (Chuanjiao)-Entada phaseoloides (Hetengzi)”. The core new formula for treating CRC was selected through topological attribute analysis. Conclusion Chinese herbal medicine patent formulas for treating CRC primarily use tonifying herbs, employing methods such as tonifying Qi and supporting the body, clearing heat and dampness, and resolving blood stasis and detoxification. The clustering of drugs focuses on Hedyotis diffusa (Baihua Sheshecao) and Scutellaria barbata D. Don (Banzhilian), which may offer new formulation ideas and provide reference for clinical treatment and new drug development for CRC.
Authors and Affiliations
ZHANG Zhaoyang , YANG Hao, WU Tengfei, ZHU Chongwei, TIAN Yun
Keywords
Related Articles
- EP ID EP745461
- DOI 10.13429/j.cnki.cjcr.2024.09.014
- Views 30
- Downloads 0
Role and mechanism of mast cells in solid tumors
Mast cells are a type of innate immune cells, and have long been considered to be related to the pathogenesis of allergic and autoimmune diseases. However, in recent years, a number of studies have found that mast cells...
Preliminary construction of a prediction model for HBV-related acute-on-chronic liver failure combined with acute kidney injury
<b>Objective</b> To establish a model that can predict the occurrence of acute kidney injury (AKI) in elderly patients with HBV-related acute-on-chronic liver failure (HBV-ACLF), and to conduct a preliminary evaluation...
Application of pancreatic regenerating protein in early warning and diagnosis of diabetes mellitus
Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are increasingly utilized in the treatment of type 2 diabetes, especially for their efficacy in weight reduction and improvement of cardiovascular and renal outcomes, a...
Trans-segmental shunt surgery for the treatment of syringomeylia resulting from trauma and infection
<b>Objective</b> To investigate the clinical effect of transsegmental shunt surgery in the treatment of syringomyelia due to trauma and infection in perspective of cerebrospinal fluid dynamics.<b>Methods</b> A total o...
Construction of a predictive model for fever in elderly patients after endoscopic mucosal dissection surgery
Objective To analyze the risk factors for postoperative fever in elderly patients after endoscopic mucosal dissection (ESD), and construct a predictive model. Methods The research subjects were 500 elderly patients who...